Emanuel K Manesis

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. doi request reprint Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B
    Emanuel K Manesis
    Division of Internal Medicine, Athens University Medical School, Athens, Greece
    J Hepatol 55:61-8. 2011
  2. doi request reprint Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study
    E K Manesis
    Liver Unit, Euroclinic, Athens, Greece
    Aliment Pharmacol Ther 29:1121-30. 2009
  3. ncbi request reprint Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring
    Emanuel K Manesis
    Academic Department of Medicine, Hippokration General Hospital, Athens, Greece
    Antivir Ther 12:381-8. 2007
  4. ncbi request reprint Prediction of treatment-related HBsAg loss in HBeAG-negative chronic hepatitis B: a clue from serum HBsAg levels
    Emanuel K Manesis
    Academic Department of Medicine, Hippokration General Hospital, Athens, Greece
    Antivir Ther 12:73-82. 2007
  5. doi request reprint The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre
    Ioannis P Giannousis
    Second Department of Internal Medicine, Athens University Medical School, Hipppokration General Hospital, Athens 115 27, Greece
    Eur J Gastroenterol Hepatol 22:172-9. 2010
  6. doi request reprint Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease
    George V Papatheodoridis
    Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital of Athens, 114 Vas Sophias Ave, 115 27 Athens, Greece
    J Clin Gastroenterol 44:e87-95. 2010
  7. doi request reprint Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    George V Papatheodoridis
    2nd Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital of Athens, Athens, Greece
    Hepatology 48:1451-9. 2008
  8. doi request reprint Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity
    Emmanuel Tsochatzis
    Second Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, Greece
    Scand J Gastroenterol 43:1128-36. 2008
  9. doi request reprint Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B
    Evangelos Cholongitas
    2nd Department of Internal Medicine, Hippokration General Hospital, National University of Athens School of Medicine, Athens, Greece
    J Med Virol 83:1165-71. 2011
  10. doi request reprint Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients
    Spilios Manolakopoulos
    2nd Academic Department of Internal Medicine, Hippokration Hospital of Athens, Athens, Greece
    Liver Int 31:1525-32. 2011

Collaborators

Detail Information

Publications21

  1. doi request reprint Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B
    Emanuel K Manesis
    Division of Internal Medicine, Athens University Medical School, Athens, Greece
    J Hepatol 55:61-8. 2011
    ....
  2. doi request reprint Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study
    E K Manesis
    Liver Unit, Euroclinic, Athens, Greece
    Aliment Pharmacol Ther 29:1121-30. 2009
    ..The effect of such treatments on the natural course of CHC has been evaluated in small clinical trials with conflicting results...
  3. ncbi request reprint Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring
    Emanuel K Manesis
    Academic Department of Medicine, Hippokration General Hospital, Athens, Greece
    Antivir Ther 12:381-8. 2007
    ..Treatment of chronic delta hepatitis is long and difficult and better monitoring is needed...
  4. ncbi request reprint Prediction of treatment-related HBsAg loss in HBeAG-negative chronic hepatitis B: a clue from serum HBsAg levels
    Emanuel K Manesis
    Academic Department of Medicine, Hippokration General Hospital, Athens, Greece
    Antivir Ther 12:73-82. 2007
    ..Quantification of HBsAg in serum may be of clinical importance in predicting HBsAg seroconversion and complete response to treatment...
  5. doi request reprint The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre
    Ioannis P Giannousis
    Second Department of Internal Medicine, Athens University Medical School, Hipppokration General Hospital, Athens 115 27, Greece
    Eur J Gastroenterol Hepatol 22:172-9. 2010
    ..To investigate the burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre...
  6. doi request reprint Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease
    George V Papatheodoridis
    Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital of Athens, 114 Vas Sophias Ave, 115 27 Athens, Greece
    J Clin Gastroenterol 44:e87-95. 2010
    ..Apoptotic caspases are substantially activated in liver and serum caspase activity has been suggested as a marker of early liver injury...
  7. doi request reprint Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    George V Papatheodoridis
    2nd Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital of Athens, Athens, Greece
    Hepatology 48:1451-9. 2008
    ..025). All inactive carriers had HBV DNA <20,000 IU/mL. Histological indication for treatment was present in 17% (6/35) of inactive carriers always due to moderate (stage 2) fibrosis without active necroinflammation...
  8. doi request reprint Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity
    Emmanuel Tsochatzis
    Second Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, Greece
    Scand J Gastroenterol 43:1128-36. 2008
    ..The objective of this study was to investigate serum levels of the above three adipokines in relation to the etiology of liver disease and to determine their associations with histological severity...
  9. doi request reprint Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B
    Evangelos Cholongitas
    2nd Department of Internal Medicine, Hippokration General Hospital, National University of Athens School of Medicine, Athens, Greece
    J Med Virol 83:1165-71. 2011
    ..In patients without substantial histological changes, treatment seems to increase the apoptosis of hepatocytes, thus having a possible protective effect on hepatocarcinogenesis...
  10. doi request reprint Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients
    Spilios Manolakopoulos
    2nd Academic Department of Internal Medicine, Hippokration Hospital of Athens, Athens, Greece
    Liver Int 31:1525-32. 2011
    ..As there are concerns about potential nephrotoxicity of nucleotide analogues, we evaluated renal function parameters during long-term adefovir and lamivudine combination therapy...
  11. ncbi request reprint Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection
    Emanuel K Manesis
    Academic Department of Medicine, Hippokration General Hospital, Athens, Greece
    Am J Gastroenterol 98:2261-7. 2003
    ..We evaluated the clinical significance of a single baseline serum HBV DNA measurement by a quantitative polymerase chain reaction (PCR) assay in this setting...
  12. doi request reprint Changes of liver and muscle enzymes activity in patients with rigor
    Nikolaos Sevastos
    2nd Department of Internal Medicine, National University of Athens Medical School, Hippokration General Hospital, 114 Vas Sophias Ave, 11527 Athens, Greece
    Eur J Intern Med 19:109-14. 2008
    ..We investigated whether changes of liver and muscle enzymes activity are associated with rigor of several causes and have any prognostic significance...
  13. ncbi request reprint Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors
    Emmanuel Tsochatzis
    2nd Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, Greece
    Am J Gastroenterol 102:634-41. 2007
    ..We determined the parameters associated with steatosis in 350 chronic hepatitis C patients, focusing on genotype 4...
  14. ncbi request reprint Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b
    Melanie Deutsch
    Academic Department of Internal Medicine, Hippokration General Hospital, Athens, Greece
    Scand J Gastroenterol 42:408-9. 2007
  15. ncbi request reprint Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis
    Nikolaos V Chrysanthos
    2nd Department of Internal Medicine, Medical School of Athens University, Athens, Greece
    Eur J Gastroenterol Hepatol 18:389-96. 2006
    ..We assessed the value of the recently developed aspartate aminotransferase to platelet ratio index (APRI) for predicting significant fibrosis or cirrhosis in patients with chronic hepatitis C or HBeAg-negative chronic hepatitis B...
  16. doi request reprint Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece c
    George V Papatheodoridis
    2nd Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, Greece
    Gut 60:1109-16. 2011
    ..To evaluate the risk and predictors of hepatocellular carcinoma (HCC) in HBeAg-negative chronic hepatitis B patients of the large HEPNET.Greece cohort study who received long-term oral antivirals starting with lamivudine monotherapy...
  17. ncbi request reprint Cholestasis in acute stroke: an investigation on its prevalence and etiology
    Nikolaos Sevastos
    Academic Department of Medicine, Hippokration General Hospital, Athens, Greece
    Scand J Gastroenterol 40:862-6. 2005
    ..Liver cholestatic enzymes and/or bilirubin occasionally occur in acute stroke and are usually, but not always, ascribed to comorbid conditions. We investigated the frequency and possible etiology of this phenomenon...
  18. ncbi request reprint Liver involvement in acute vaso-occlusive crisis of sickle cell disease: prevalence and predisposing factors
    John Koskinas
    Academic Department of Medicine, Hippokration General Hospital, 114 Vas Sophias Avenue, GR 11527 Athens, Greece
    Scand J Gastroenterol 42:499-507. 2007
    ..To study the prevalence and predisposing factors of liver involvement in sickle cell disease (SCD) of patients with acute vaso-occlusive crisis...
  19. ncbi request reprint Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen-negative chronic hepatitis B virus infection
    George V Papatheodoridis
    Hepatology 46:606-7; author reply 607. 2007
  20. ncbi request reprint HBeAg-negative chronic hepatitis B: from obscurity to prominence
    Emanuel K Manesis
    J Hepatol 45:343-6. 2006
  21. ncbi request reprint Serum HBV-DNA levels in inactive hepatitis B virus carriers
    Emanuel K Manesis
    Gastroenterology 122:2092-3; author reply 2093. 2002